ID

12754

Descrizione

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01518517

collegamento

https://clinicaltrials.gov/show/NCT01518517

Keywords

versioni (1)
  1. 21/12/15 21/12/15 -
Caricato su

21 dicembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

Inglese

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient from 1 to 55 years old (children and adolescents from 1 to 17 years/ adults from 18 to 55 years)
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
patients with 1st all relapse, which could be either isolated bone marrow relapse, or combined (medullary and extra-medullary) relapse, or extra-medullary isolated relapse; or lymphoblastic lymphoma (excepted burkitt lymphoma) or failure to all first line treatment (no complete remission obtained)
Descrizione

ALL relapse first

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2367454
UMLS CUI [1,2]
C0205435
patient previously treated with free e.coli l-asparaginase form or pegylated one
Descrizione

Therapy l-asparaginase (E.Coli)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C3255308
performance status ≤ 2 (who score)
Descrizione

WHO performance status scale

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1298650
patient informed and consent provided (the 2 parents need to consent when children are below 18)
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
all t(9;22) and/or bcr-abl positive (philadelphia chromosome positive)
Descrizione

philadelphia chromosome positive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0856536
patient with 2nd relapse and over
Descrizione

Leukaemia recurrent second

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0920028
UMLS CUI [1,2]
C0205436
women of childbearing potential without effective contraception as well as pregnant or breast feeding women
Descrizione

Lactating; Patient currently pregnant; Contraception status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
UMLS CUI [3]
C0420837
patient unable to receive treatments used in global chemotherapy protocols, due to general or visceral conditions such as:severe cardiac impairment (nyha grade 3 or 4 cardiomyopathy)/serum creatinine 2 x uln unless related to all /alt or ast 5 x uln unless related to all /pancreatitis history /other malignancy that all / severe infection, hiv positive, active hepatitis related to b or c virus infection / trisomy 21 / other serious conditions according to investigator's opinion
Descrizione

chemotherapy limited Comorbidity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3665472
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
known grade 4 allergic reaction to e.coli l-asparaginase (according nci-ctcae, version 3.0)
Descrizione

allergy e.coli l-asparaginase

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3255308
history of grade 3 transfusional incident
Descrizione

Transfusion Grade three rank

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1879316
UMLS CUI [1,2]
C0450094
presence of specific anti-erythrocyte antibodies preventing from getting a compatible erythrocyte concentrate for the patient
Descrizione

Antierythrocyte Antibody

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0236506
patient under concomitant treatment likely to cause hemolysis
Descrizione

hemolysis; Concomitant Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019054
UMLS CUI [2]
C1707479
patient undergoing yellow fever vaccination
Descrizione

yellow fever vaccination

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0199823
patient under phenytoin treatment
Descrizione

phenytoin treatment

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0747579
patient included in previous clinical study less than 6 weeks ago
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Ritorna all'inizio della pagina

Similar models

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patient from 1 to 55 years old (children and adolescents from 1 to 17 years/ adults from 18 to 55 years)
boolean
C0001779 (UMLS CUI [1])
ALL relapse first
Item
patients with 1st all relapse, which could be either isolated bone marrow relapse, or combined (medullary and extra-medullary) relapse, or extra-medullary isolated relapse; or lymphoblastic lymphoma (excepted burkitt lymphoma) or failure to all first line treatment (no complete remission obtained)
boolean
C2367454 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
Therapy l-asparaginase (E.Coli)
Item
patient previously treated with free e.coli l-asparaginase form or pegylated one
boolean
C0087111 (UMLS CUI [1,1])
C3255308 (UMLS CUI [1,2])
WHO performance status scale
Item
performance status ≤ 2 (who score)
boolean
C1298650 (UMLS CUI [1])
informed consent
Item
patient informed and consent provided (the 2 parents need to consent when children are below 18)
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
philadelphia chromosome positive
Item
all t(9;22) and/or bcr-abl positive (philadelphia chromosome positive)
boolean
C0856536 (UMLS CUI [1])
Leukaemia recurrent second
Item
patient with 2nd relapse and over
boolean
C0920028 (UMLS CUI [1,1])
C0205436 (UMLS CUI [1,2])
Lactating; Patient currently pregnant; Contraception status
Item
women of childbearing potential without effective contraception as well as pregnant or breast feeding women
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
C0420837 (UMLS CUI [3])
chemotherapy limited Comorbidity
Item
patient unable to receive treatments used in global chemotherapy protocols, due to general or visceral conditions such as:severe cardiac impairment (nyha grade 3 or 4 cardiomyopathy)/serum creatinine 2 x uln unless related to all /alt or ast 5 x uln unless related to all /pancreatitis history /other malignancy that all / severe infection, hiv positive, active hepatitis related to b or c virus infection / trisomy 21 / other serious conditions according to investigator's opinion
boolean
C3665472 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
allergy e.coli l-asparaginase
Item
known grade 4 allergic reaction to e.coli l-asparaginase (according nci-ctcae, version 3.0)
boolean
C0020517 (UMLS CUI [1,1])
C3255308 (UMLS CUI [1,2])
Transfusion Grade three rank
Item
history of grade 3 transfusional incident
boolean
C1879316 (UMLS CUI [1,1])
C0450094 (UMLS CUI [1,2])
Antierythrocyte Antibody
Item
presence of specific anti-erythrocyte antibodies preventing from getting a compatible erythrocyte concentrate for the patient
boolean
C0236506 (UMLS CUI [1])
hemolysis; Concomitant Therapy
Item
patient under concomitant treatment likely to cause hemolysis
boolean
C0019054 (UMLS CUI [1])
C1707479 (UMLS CUI [2])
yellow fever vaccination
Item
patient undergoing yellow fever vaccination
boolean
C0199823 (UMLS CUI [1])
phenytoin treatment
Item
patient under phenytoin treatment
boolean
C0747579 (UMLS CUI [1])
Study Subject Participation Status
Item
patient included in previous clinical study less than 6 weeks ago
boolean
C2348568 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial